Addex Therapeutics (ADXN) Stock: Buy, Sell, or Hold?
ADXN - Addex Therapeutics Ltd American Depositary Shares
$3.10
0.03 (0.98%)
▲
5d:
+10.32%
30d:
-16.44%
90d:
-52.31%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Sep 28, 2026
0d
Get Alerted When ADXN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ADXN shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ADXN shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: ADXN is currently trading at $3.10, which is considered oversold relative to its 30-day fair value range of $3.12 to $3.73.
Technical Outlook: Technically, ADXN is in a strong downtrend. Immediate support is located at $2.56, while resistance sits at $3.80.
Market Sentiment: ADXN scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $30.00 (+877.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ADXN is in a strong downtrend. Immediate support is located at $2.56, while resistance sits at $3.80.
Market Sentiment: ADXN scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $30.00 (+877.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.12 -
$3.73
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 877.2% below Wall St target ($30.00)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.12 -
$3.73
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.56
Resistance Level
$3.80
Current Trend
Strong Downtrend
Technical data as of
Oct 5, 2026
Fundamental Context
Wall Street Target
$30.00
(+877.2%)
Revenue Growth (YoY)
-72.7%
Share & Embed Analysis
Last updated: October 05, 2026 2:32 PM ET
Data refreshes hourly during market hours. Next update: 3:32 PM
Data refreshes hourly during market hours. Next update: 3:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADXN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
23 analysts |
$257 | 48 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$74 | 62 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
20 analysts |
$95 | 54 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$36 | 64 BUY |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
15 analysts |
$52 | 68 BUY |
